#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hydrocephalus Optic ischaemic neuropathy Prodromal Alzheimer's disease Hyperinsulinism Malignant fibrous histiocytoma Pulmonary hypertension Mycobacterium abscessus infection Necrotising enterocolitis neonatal Malignant glioma Anti-myelin-associated glycoprotein associated polyneuropathy Haemophilia A with anti factor VIII Paraneoplastic neurological syndrome Renal disorder Pulmonary tuberculosis Dermatomyositis More trials…

    Learn about Rare Diseases

    Primary mediastinal large B-cell lymphoma – Trials in Disease Synovial sarcoma metastatic – Trials in Disease Alagille syndrome Castleman’s disease – Trials in Disease Factor IX deficiency – Life with Disease Pemphigoid – Diagnostics Nephrotic syndrome – Life with Disease Lennox-Gastaut syndrome – Diagnostics Arterial tortuosity syndrome – Treatment Gaucher’s disease type I – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sot102 ADX-038 Sasanlimab Chloroprocaine Hydrochloride Brimonidine Boserolimab Sirexatamab Hydroxi-Methionine Calcium LY3537021 Clenbuterol Hydrochloride 534 AUROCELL-TX Vobramitamab Duocarmazine Duloxetine Rosnilimab Zolbetuximab Nemolizumab Sphingomyelin (Egg) TEDUGLUTIDE Raxtozinameran More therapies…

    Learn about Your Condition

    Deep vein thrombosis Oesophageal cancer metastatic Acute cardiac event Osteogenesis imperfecta Small for dates baby Mixed-type liposarcoma Thyroid cancer Kearns-Sayre syndrome Vulval cancer Neonatal asphyxia Blood iron increased Hypoxia Dermatomyositis Meniscus operation Metastases to peritoneum More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Cliniques Universitaires Saint-Luc

Cliniques Universitaires Saint-Luc

Hippokrateslaan 10, Batiment 54, Woluwe-Saint-Lambert, 1200, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Dostarlimab
    Belgium Czechia France Germany Greece Hungary +7

  • Study on the Safety and Effects of Tolvaptan for Children with Autosomal Recessive Polycystic Kidney Disease (ARPKD)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Congenital cystic kidney disease
    Investigated Drugs:
    • Tolvaptan
    Belgium Germany Poland Spain

  • Study of Patritumab Deruxtecan for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Drugs:
    • Patritumab Deruxtecan
    Belgium France Germany Hungary Italy The Netherlands +2

  • Study on Long-Term Safety of Tolebrutinib and Teriflunomide for Patients with Multiple Sclerosis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Progressive relapsing multiple sclerosis
    • Relapsing multiple sclerosis
    • Secondary progressive multiple sclerosis
    Investigated Drugs:
    • Anhydrous Cholestyramine
    • Magnetic Resonance Imaging Contrast Media
    • Teriflunomide
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study Comparing MK-2870 and Pembrolizumab with Chemotherapy for Patients with Advanced Hormone Receptor Positive Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Buclizine Hydrochloride
    • Codeine Phosphate
    • H2-Receptor Antagonists
    Belgium Czechia Denmark France Germany Greece +10

  • Study on Stiripentol for Patients Aged 6 and Older with Primary Hyperoxaluria Types 1, 2, or 3

    Recruiting

    3 1 1
    Investigated Diseases:
    • Primary hyperoxaluria
    Investigated Drugs:
    • Stiripentol
    Belgium France Italy

  • Study of Epoetin Alfa for Critically Ill Patients with Traumatic Injury

    Recruiting

    3 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Epoetin Alfa
    Belgium Finland France Germany Ireland Slovenia

  • Study Comparing Vincristine, Actinomycin-D, and Doxorubicin with Vincristine, Carboplatin, and Etoposide for Stage IV Childhood Kidney Cancer Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephroblastoma
    Investigated Drugs:
    • Dactinomycin
    • Carboplatin
    • Doxorubicin Hydrochloride
    Austria Belgium Czechia Denmark France Germany +5

  • Study on the Safety and Effects of Divarasib with Pembrolizumab and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with KRAS G12C Mutation

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Budesonide
    • Divarasib
    • Carboplatin
    Belgium Italy The Netherlands Poland Spain Sweden

  • Study on Darolutamide and Radiation Therapy for Patients with Castration-Resistant Prostate Cancer and Oligometastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Darolutamide
    • Degarelix
    • Leuprorelin Acetate
    Belgium France Ireland Spain
Previous Page
1 … 17 18 19 20 21 … 67
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!